Clinical trials
Completed HIV Infections trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
299 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 10 |
| 2001 | 9 |
| 2002 | 10 |
| 2003 | 10 |
| 2004 | 13 |
| 2005 | 10 |
| 2006 | 16 |
| 2007 | 13 |
| 2008 | 9 |
| 2009 | 10 |
| 2010 | 6 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 299 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 168 |
| Gilead Sciences | 20 |
| University of North Carolina, Chapel Hill | 17 |
| Bristol-Myers Squibb | 14 |
| Hoffmann-La Roche | 10 |
| Glaxo Wellcome | 7 |
| ViiV Healthcare | 7 |
| AIDS Malignancy Consortium | 5 |
| Abbott | 5 |
| Boehringer Ingelheim | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 299 |
| Acquired Immunodeficiency Syndrome | 83 |
| AIDS-Related Complex | 47 |
| Pregnancy Complications, Infectious | 14 |
| AIDS-Related Opportunistic Infections | 10 |
| Hepatitis C | 7 |
| Pneumonia, Pneumocystis | 7 |
| Infections | 5 |
| Lipodystrophy | 5 |
| Anus Neoplasms | 4 |
Trials
Showing 1 to 25 of 299. Each trial links to its page on Pharma Observatory.
199 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.